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Abstract
The relationship between homovanillic acid
(HVA), vanillylmandelic acid (VMA), and
creatinine in the urine of 6 month old babies
has been studied and reference ranges in the
form of centiles constructed for HVA and
VMA against creatinine. Over 10000 urine
samples were collected from babies in four
health districts in the north of England. HVA
and VMA concentration, either independently
or when divided by creatinine concentration,
were dependent upon the absolute concentra-
tion of creatinine in the sample. After adjust-
ment for creatinine significant differences in
the mean concentration of HVA were found
between sexes. No such differences were
found for VMA. HVA and VMA were also
found to be age dependent.
Centiles were constructed using a procedure
which makes no distributional assumptions
about the data. The net effect of utilising these
centiles was to increase the predictive value of
a positive screening test from 20% to 40%
without any increase in the false negative rate.
(Arch Dis Child 1993; 68: 376-378)
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Estimation of the urinary excretion of the
catecholamine metabolites homovanillic acid
(HVA) and vanillylmandelic acid (VMA) has
been a major factor in the diagnosis of neuro-
blastoma in children since the first report in 1957
of such an association.' In over 92% of cases of
neuroblastoma the presence of the tumour is
accompanied by an increased concentration of
urinary HVA and/or VMA excretion.2 Reference
ranges for HVA and VMA have typically been
based on small numbers of samples often taken
from children hospitalised for unrelated medical
conditions. Due to practical difficulties in obtain-
ing timed urine collections and because of the
dilution that occurs during the analytical phase it
has become customary to express the output of
HVA and VMA as their ratio to creatinine (Cr).
The statistical methods employed to determine
reference ranges for HVA:Cr and VMA:Cr often
make distributional assumptions about the data
which may not be justifiable. The pilot neuro-
blastoma studies in the Northern region of
England have provided an opportunity to
explore the relationship between HVA, VMA,
and creatinine.
Methods
Urine samples were collected from 6 month old
babies in the four health districts, North Tyne-
side, South Tyneside, Gateshead, and North
Tees. A detailed audit was undertaken in 1989 in
North Tyneside that revealed that 93% of the
births for that year had been screened. The
samples were obtained, usually by health
visitors, by pressing a filter paper onto a wet but
unsoiled nappy. Parents were told that they were
taking part in a pilot screening programme to try
to detect a rare form of cancer. Ethical permis-
sion had been obtained from the local ethical
committees.
Each sample was subsequently analysed by gas
chromatography - mass spectrometry for HVA
and VMA and by an automated reaction rate
picrate method for creatinine. Full details of
urine collection and analytical methods have
been described elsewhere.3' Repeat urine
samples were collected when there was either an
inadequate sample (insufficient urine) or a dilute
urine with creatinine concentration of less than
100 iimol/l. The upper limit of normal for
HVA:Cr and VMA:Cr had been established
during the early phase of the study.3 The 'cut off'
concentration above which babies would be
selected for further investigation was chosen as
the mean plus 3 SD; 24-2 pmol:mmol creatinine
for HVA:Cr and 14 7 iimol:mmol creatinine for
VMA:Cr.
This report is based on the results obtained
from the first biochemical analysis carried out on
each child's urine sample where the creatinine
concentration was found to be greater than 100
Fmol/l. All children screened between 20 and 40
weeks were included but known cases of neuro-
blastoma were excluded. Centiles were con-
structed using a random sample of 1000 eligible
results.
The procedure used for centile construction
was that ofHealy et al,5 which makes no distribu-
tional assumptions about the data. The method
involves fitting the separate centiles with a series
of polynomials whose coefficients are con-
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Figure 2 VMA:Cr compared with creatinine (n= 10044).
strained to change smoothly. These were con-
structed for HVA against creatinine and for
VMA against creatinine.
Results
The 10044 children from whom samples were
eligible for this analysis consisted of 5089 boys
and 4955 girls. The distribution of age at screen-
ing is shown in fig 1. The median age at screening
was 27 weeks, range 20 to 40 weeks. There were
insufficient data to construct accurate centiles for
creatinine concentrations greater than 1200
,umol/l. HVA and VMA concentration, either
independently or when divided by creatinine
concentration (that is HVA:Cr and VMA:Cr),
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Figure 3 Centiles:VMA compared with creatinine (boys and girls). Centiles shown are those
equivalent to 'mean+2 SD and mean+3 SD'for data with a Gaussian distribution
(n= 10044).
were dependent upon the absolute concentration
of creatinine in the sample. Figure 2 shows the
results for VMA:Cr against creatinine. Analysis
of covariance (ANCOVA) revealed a significant
difference in the mean concentration of HVA
between sexes using creatinine as a covariate
(p=0-001). This was not the case for VMA (p=
0-662). Figures 3 to 5 show the 97-72th and
99-86th centiles for VMA against creatinine
and HVA against creatinine, HVA is-shown
separately for boys and girls. These centiles are
equivalent to the mean plus 2 SD and 3 SD for
data which has a Gaussian distribution. Super-
imposed is a scatter plot of the 10044 data points
from which the random sample was chosen and
the centiles were derived.
HVA and VMA are age dependent as well as
creatinine dependent. After adjusting for
creatinine and sex HVA and VMA were found to
be dependent upon age, p=0 003 and p=0006,
respectively (ANCOVA). Although the depen-
dency was highly significant the size of the effect
was small. The mean concentration of HVA
decreases by 0-076 ,tmol/l (95% confidence
interval (CI) 0-026 to 0 126) per one month
increase in age. A change of the same magnitude
occurs for a decrease in creatinine of only 8-7
[imol/l. For VMA the mean concentration
decreases by 0 039 itmol/l (95% CI 0-011 to
0-067) per one month increase in age. A change
in VMA of the same magnitude occurs for a
decrease in creatinine of just 6-9 ,tmol/l.
Discussion
The introduction of whole population screening
programmes for the early detection of neuro-
blastoma using urinary HVA and VMA has
necessitated the establishment of reliable refer-
ence ranges for these urinary metabolites. In the
present study the distributions of HVA and
VMA concentration in the urine, even when
divided by creatinine concentration, were found
to be dependent upon the absolute concentration
of creatinine. Tuchman et al reporting on the
results of the first 5000 urine samples from the
Quebec study also found that HVA:Cr and
VMA:Cr were not independent of the absolute
creatinine concentration.6 However they did
not report any difference between males and
females.
Problems encountered when dealing with
ratios, such as HVA:Cr, have been known for a
long time.7 Recently, Kronmal has again high-
lighted these problems and proposed modelling
the relationship between two variables directly
rather than assuming a specific relationship,
even implicitly, as with HVA:Cr (RA Kronmal,
personal communication). Thompson et al drew
a similar conclusion from a study to determine
how urinary cotinine concentration should be
adjusted for urinary creatinine concentration.8
The adjustment of HVA and VMA concentra-
tion for the absolute concentration of creatinine
in this study has been modelled directly.
The procedure usually recommended for the
construction of centiles involves calculating the
mean and SD of the measurement at each of a
series of creatinine concentrations. This is
similar to the production of age related centiles,
.
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Figure 4 Centiles:HVA compared with creatinine (boys) Centiles shown are those equivalent
to 'mean +2 SD and mean +3 SD'for data with a Gaussian distribution (n=5089).
for example for height and weight.9 Centiles are
produced by assuming that the distribution of
HVA or VMA at a fixed creatinine concentration
has a Gaussian distribution. When this assump-
tion is justified this method is highly efficient,
however when the assumption is not justified the
method is unsatisfactory.'" In contrast, the pro-
cedure of Healy et al used in this paper makes no
distributional assumptions.5
After adjustment for creatinine, HVA and
VMA were found to be age dependent, although
the size of the effect was small. It would be
possible to produce reference ranges of HVA
and VMA against creatinine after adjustment for
age, however the adjustment would be of little
practical significance.
For 6 month old babies the importance of
relating the upper limit of normal for HVA:Cr
and VMA:Cr to creatinine concentration is well
demonstrated by the results of the pilot study in
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Figure 5 Centiles:HVA compared with creatinine (girls). Centiles shown are those equivalent
to 'mean+2 SD and mean+3 SD' for data with a Gaussian distribution (n=4995).
the north of England.4 Of the 20829 babies
screened 10 were found to have values of HVA:
Cr and/or VMA:Cr which were above the
original upper limit of mean plus 3 SD, that is
24-2 ,tmol:mmol creatinine for HVA:Cr and
14-7 ,tmol:mmol creatinine for VMA:Cr. Two
of these 10 children were found to have a
neuroblastoma and the other eight were desig-
nated false positives. Utilising the centiles
reported in this -paper only five of the. 10,
including the two children with neuroblastoma,
would have remained positive (that is above the
equivalent centile). Any reduction in the false
positive rate is of paramount importance as it
reduces the amount of unnecessary investigation
and consequent anxiety engendered in the
families. The net effect of utilising these centiles
has been to increase the predictive value of a
positive test from 20% to 40% without any
increase in the associated number of false
negative cases.
Several explanations have been suggested for
the dependency ofHVA:Cr and VMA:Cr on the
absolute concentration of creatinine. These
include the differential extraction of HVA,
VMA, and creatinine from the filter paper, the
use of wet filter papers - that is drying filter
papers at the laboratory rather than at the point
of collection, bacterial contamination leading
to destruction of creatinine, some effect of
creatinine like chromogens, and finally a statisti-
cal effect generated by considering the ratio of
two random variables. Whatever the explanation
the phenomenon exists and must be taken into
account when constructing reference ranges for
HVA and VMA. Many other urinary bio-
chemical measurements such as albumin,
protein and calcium are also traditionally expres-
sed as a ratio to creatinine concentration. The
extent to which these ratios are still dependent
upon creatinine concentration should be asses-
sed and if required similar methods to those
presented in this paper should be adopted for the
construction of reference ranges.
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